ClinicalTrials.Veeva

Menu

Automated Imaging Differentiation of Parkinsonism (AIDP)

University of Florida logo

University of Florida

Status

Active, not recruiting

Conditions

Parkinson Disease
Multiple System Atrophy, Parkinson Variant
Progressive Supranuclear Palsy

Treatments

Diagnostic Test: AIDP

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT05913687
IRB202002350
PRO00028349 (Other Identifier)
5U01NS119562 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagnostic algorithm and the imaging diagnosis will be compared to the movement disorders trained neurologist diagnosis.

Enrollment

315 estimated patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Parkinson's disease diagnosis within 5-9 years of baseline date
  • MSAp diagnosis
  • PSP diagnosis

Exclusion criteria

  • metal implants in the body that preclude an MRI (pacemaker, metallic clip, neurostimulator, etc)
  • claustrophobia
  • pregnancy

Trial design

315 participants in 3 patient groups

Parkinson's disease
Description:
Clinically diagnosed Parkinson's disease
Treatment:
Diagnostic Test: AIDP
Multiple System Atrophy, Parkinsonian variant
Description:
Clinically diagnosed Multiple System Atrophy, Parkinsonian variant
Treatment:
Diagnostic Test: AIDP
Progressive Supranuclear Palsy
Description:
Clinically diagnosed Progressive Supranuclear Palsy
Treatment:
Diagnostic Test: AIDP

Trial contacts and locations

21

Loading...

Central trial contact

David Vaillancourt, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems